Talphera (TLPH) Capital Expenditures (2011 - 2023)
Talphera (TLPH) posted Capital Expenditures of $100000.0 for Q1 2023, up 108.33% on a QoQ basis from $48000.0 in Q4 2022, and up 12.36% year-over-year from $89000.0 in Q1 2022.
Analysis
Talphera (TLPH) Capital Expenditures (2011 - 2023) Analysis & Trends
Talphera has reported Capital Expenditures for 13 years, with the latest figure at $100000.0 in Q1 2023.
- On a quarterly basis, Capital Expenditures rose 12.36% year-over-year to $100000.0 in Q1 2023; TTM through Dec 2023 was $100000.0, a 72.53% decrease from a year earlier, with the FY2023 full-year figure at $100000.0, down 72.53% from the prior year.
- Capital Expenditures was $100000.0 for Q1 2023 at Talphera, up from $48000.0 in the prior quarter.
- The five-year high for Capital Expenditures was $1.6 million in Q4 2020, with the low at $24000.0 in Q1 2021.
- Average Capital Expenditures over 5 years is $448000.0, with a median of $100000.0 recorded in 2023.
- The largest YoY upside for Capital Expenditures was 1540.21% in 2021 against a maximum downside of 98.28% in 2021.
- Over 5 years, Capital Expenditures stood at $242000.0 in 2019, then surged by 573.97% to $1.6 million in 2020, then tumbled by 98.28% to $28000.0 in 2021, then surged by 71.43% to $48000.0 in 2022, then soared by 108.33% to $100000.0 in 2023.
- The last three Capital Expenditures figures came in at $100000.0 (Q1 2023), $48000.0 (Q4 2022), and $158000.0 (Q3 2022), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 513.00 Mn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 140.00 Mn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 112.20 Mn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 240.20 Mn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 37.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 34.68 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 40.90 Mn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | -1.87 Mn |
| 10 | Talphera | 92.90 Mn | 92.90 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2023 | 100,000.00 |
| Dec 31, 2022 | 48,000.00 |
| Sep 30, 2022 | 158,000.00 |
| Jun 30, 2022 | 69,000.00 |
| Mar 31, 2022 | 89,000.00 |
| Dec 31, 2021 | 28,000.00 |
| Sep 30, 2021 | 184,000.00 |
| Jun 30, 2021 | 1.59 Mn |
| Mar 31, 2021 | 24,000.00 |
| Dec 31, 2020 | 1.63 Mn |
| Sep 30, 2020 | 54,000.00 |
| Jun 30, 2020 | 97,000.00 |
| Mar 31, 2020 | 73,000.00 |
| Dec 31, 2019 | 242,000.00 |
| Sep 30, 2019 | 1.44 Mn |
| Jun 30, 2019 | 1.13 Mn |
| Mar 31, 2019 | 658,000.00 |
| Dec 31, 2018 | 246,000.00 |
| Sep 30, 2018 | 186,000.00 |
| Jun 30, 2018 | 179,000.00 |